Table 1.
Case # | Gender | Age at Diagnosis | Diagnosis | Tumour Location |
---|---|---|---|---|
1 | M | 7 y | GN | Posterior mediastinum |
2 | F | 7 days | NB | Presacral |
3 | F | 9 m | NB | Posterior mediastinum |
4 | M | 12 m | NB | Presacral |
5 | M | 8 y 3 m | GN | Retroperitoneum |
6 | M | 32 m | GNB | Carotid bifurcation |
7 | M | 3 y 8 m | NB | Retroperitoneum |
8 | M | 3 m | NB | Retroperitoneum |
9 | M | 9 y 8 m | GN | Presacral |
10 | F | 9 m | NB | Paravertebral |
11 | F | 5 y 7 m | GNB | Paravertebral |
12 | F | 9 m | NB | Presacral |
13 | M | 3 days | NB | Posterior mediastinum |
14 | F | 15 y 11 m | GN | Suprarenal |
15 | F | 12 y 1 m | GN | Suprarenal |
16 | M | 6 y 4 m | GNB | Suprarenal |
17 | M | 7 m | NB | Posterior mediastinum |
18 | F | 17 m | NB | Posterior mediastinum |
19 | F | 4 y | NB | Retroperitoneum |
20 | M | 17 m | NB | Posterior mediastinum |
21 | M | 5 m | NB | Suprarenal |
22 | M | 13 m | NB | Suprarenal |
23 | F | 13 m | GNB | Posterior mediastinum |
24 | M | 9 y 10 m | NB | Suprarenal |
25 | M | 3 y 11 m | NB | Suprarenal |
26 | F | 3 y 8 m | NB | Presacral |
27 | M | 11 y 7 m | GNB | Retroperitoneum |
28 | F | 36 m | NB | Suprarenal |
29 | F | 3 y 2 m | GN | Posterior mediastinum |
30 | F | 1 m | NB | Posterior mediastinum |
31 | M | 17 days | NB | Neck |
32 | F | 2 y 4 m | NB | Paravertebral |
33 | F | 4 y 4 m | GNB | Suprarenal |
34 | M | 14 y 7 m | GN | Retroperitoneum |
35 | M | 16 y 7 m | GN | Posterior mediastinum |
36 | F | 6 y 11 m | GN | Retroperitoneum—intramuscular |
37 | F | 1 y 9 m | NB | Posterior mediastinum |
38 | M | 3 m | NB | Retroperitoneum |
39 | M | 1 m 22 d | NB | Retroperitoneum—intramuscular |
40 | M | 15 y 7 m | GN | Retroperitoneum |
Median (months) | 34 (2 y 10 m) | |||
Females = 18 (45%) | Mean (months) | 54.7 (4 y 6 m) | ||
Min. | 7 days | |||
Max. | 16 y 7 m | |||
SD (months) | 60.2 (5 y) |
Abbreviations: M, male; F, female; y, years; m, months; NB, neuroblastoma; GNB, ganglioneuroblastoma; GN, ganglioneuroma; SD, standard deviation.